Literature DB >> 33454397

Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: A multicenter cross-sectional study.

Davide Cattaneo1, Elisa Gervasoni2, Denise Anastasi1, Rachele Di Giovanni3, Giampaolo Brichetto4, Ilaria Carpinella1, Paola Cavalla5, Paolo Confalonieri6, Elisabetta Groppo7, Luca Prosperini8, Andrea Tacchino4, Marco Rovaris1, Claudio Solaro3.   

Abstract

BACKGROUND: Motor and cognitive disorders appear early in the course of multiple sclerosis (MS) and develop gradually over time.
OBJECTIVE: To study the frequency and pattern of subtle functional disorders in people with MS (PwMS) with no overt signs of disability in an early phase of the disease and their association with walking impairments in daily activities.
METHODS: In this cross-sectional study, we recruited PwMS with an Expanded Disability Status Scale (EDSS) score≤2.5 and disease duration≤5years. Participants were assessed with functional scales rating walking endurance (6-Min Walk Test), perceived walking ability (Twelve-item Multiple Sclerosis Walking Scale), balance (Fullerton Advanced Balance scale_short), manual dexterity (Nine Hole Peg Test), fatigue (Fatigue Severity Scale), and cognitive impairments (Brief International Cognitive Assessment).
RESULTS: About 90% of the 82 PwMS (mean [SD] EDSS score 1.5 [0.7] and disease duration 2.2 [1.7] years) showed endurance values below the expected score; almost 30% showed impairment, and for 57%, perceived walking ability score was abnormal. Balance was impaired in 48% of participants, as was manual dexterity (29%) and fatigue (24%), but only a few showed cognitive impairments. Only 11% of PwMS had no abnormal score on the scales used in the assessment. As compared with EDSS score 0 to 1.5, with EDSS score 2 to 2.5, performance was worse for endurance (difference±61.0m, P=0.016), perceived walking ability (-11 points, P=0.002), balance (+1.9 points, P=0.005), manual dexterity (-2.8 s, P=0.004), and fatigue (-1.3 points, P=0.013). Factors that predicted perceived walking ability were balance (B=-1.37, P<0.001) and fatigue (B=5.11, P<0.001) rather than endurance (B=-0.01, P=048).
CONCLUSION: Even PwMS with no clinical disability and classified as having "no problem walking" present walking and other functional deficits when assessed with specific functional tests. The addition of specific tools could better identify subtle motor and cognitive deficits. Finally, the assessment of balance disorders and fatigue is important to understand individuals' perceived walking impairments in daily activities.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Balance; Cognition; Early multiple sclerosis; Fatigue; Functional disorders; Walking

Mesh:

Year:  2021        PMID: 33454397     DOI: 10.1016/j.rehab.2021.101491

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  4 in total

1.  The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.

Authors:  Raffaello Bonacchi; Alessandro Meani; Elisabetta Pagani; Olga Marchesi; Massimo Filippi; Maria A Rocca
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 4.849

2.  Walking With Horizontal Head Turns Is Impaired in Persons With Early-Stage Multiple Sclerosis Showing Normal Locomotion.

Authors:  Ilaria Carpinella; Elisa Gervasoni; Denise Anastasi; Rachele Di Giovanni; Andrea Tacchino; Giampaolo Brichetto; Paolo Confalonieri; Claudio Solaro; Marco Rovaris; Maurizio Ferrarin; Davide Cattaneo
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

Review 3.  The pathophysiology of motor fatigue and fatigability in multiple sclerosis.

Authors:  Robert Patejdl; Uwe K Zettl
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

4.  Effects of vibration training on motor and non-motor symptoms for patients with multiple sclerosis: A systematic review and meta-analysis.

Authors:  Yang Zhang; Peng Xu; Yu Deng; Wenxiu Duan; Juncai Cui; Chaomin Ni; Ming Wu
Journal:  Front Aging Neurosci       Date:  2022-08-05       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.